Want to join the conversation?
$ABBV 2Q15 Call: Adjusted earnings per share of a dollar $0.08, representing a growth of more than 31% vs. 2Q14. Our results included strong operational sales growth of nearly 20% driven by a number of products across our portfolio, including strong performance from our newly acquired oncology therapy Imbruvica.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.